Skip to content

Clinical trials

Completed Neurofibromatoses trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurofibromatoses Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20062
20071
20092
20101
20113
20124
20143
20152
20172
20181
20191
20201
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital6
National Cancer Institute (NCI)5
Indiana University2
University of Alabama at Birmingham2
Assistance Publique - Hôpitaux de Paris1
FDA Office of Orphan Products Development1
Harry T Whelan, MD1
Kent Robertson1
M.D. Anderson Cancer Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurofibromatoses32
Neurofibromatosis 113
Neurofibroma6
Neurofibroma, Plexiform6
Neurofibromatosis 25
Neoplasms3
Brain Neoplasms2
Leukemia2
Neuroma, Acoustic2
Abdominal Neoplasms1

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.